Angiodynamics ANGO
NASDAQ ANGO
$15.73 -0.09 (-0.57%)
As of: Aug 21, 2026 · 10:01 AM EDT

Angiodynamics (ANGO) Divestments (2023 - 2024)

Angiodynamics' (ANGO) quarterly Divestments came in at $34.5 million in Q1 2024, down 65.5% on a QoQ basis from $100.0 million in Q3 2023.

Angiodynamics (ANGO) Divestments (2023 - 2024) Analysis & Trends

Angiodynamics (ANGO) has 2 years of Divestments data on file, last reported at $34.5 million in Q1 2024.

  • Quarterly Divestments changed N/A year-over-year to $34.5 million in Q1 2024, while the trailing twelve-month figure through Nov 2024 was $34.5 million (down 65.5% YoY) and the FY2024 annual result came in at $134.5 million, changed N/A from the prior year.
  • Divestments retreated to $34.5 million in Q1 2024, from $100.0 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $100.0 million in Q3 2023 to a low of $34.5 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Intuitive Surgical 133.35 Bn 128.13 Bn 1.96 Bn -
2 Becton Dickinson 52.06 Bn 51.19 Bn 2.32 Bn 13.00 Mn
3 Alcon 35.47 Bn 34.12 Bn 1.68 Bn -
4 Resmed 33.46 Bn 31.99 Bn 861.22 Mn -
5 Medline 28.58 Bn 25.90 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.05 Bn 24.61 Bn 329.20 Mn -
7 Solventum 15.29 Bn 14.88 Bn 1.29 Bn -
8 Cooper Companies 14.83 Bn 14.69 Bn 735.40 Mn -
9 Baxter International 13.55 Bn 11.40 Bn 1.03 Bn -
10 Angiodynamics 653.62 Mn 599.76 Mn 46.77 Mn -

Historic Data

Download Data
DateValue
Feb 29, 2024 34.50 Mn
Aug 31, 2023 100.00 Mn